Heart Failure Clinics

Article	Citations
Tafamidis in the Treatment of ATTR-related Cardiomyopathy	26
Unusual Forms of Pulmonary Hypertension	23
Valvular Regurgitation in Adults with Congenital Heart Disease and Heart Failure	22
Genetic Risk Stratification in Arrhythmogenic Left Ventricular Cardiomyopathy	21
When all Else Fails, Try This	20
Forthcoming Issues	19
Changing Landscape of Heart Failure Imaging	18
Viral Myocarditis and Dilated Cardiomyopathy as a Consequence—Changing Insights from Advanced Imaging	17
Understanding Myocardial Metabolism in the Context of Cardio-Oncology	15
Emerging Targeted Therapies for Inherited Cardiomyopathies and Arrhythmias	14
Therapy-Related Clonal Hematopoiesis	13
Patient Selection, Referral Timing, and Advanced Heart Disease Therapy Options for Heart Failure with Reduced Ejection Fraction	13
Contributors	13
Mitral Regurgitation	12
Heart Failure in Adults with Congenital Heart Disease: The Time to Act is Now	12
Contributors	12
Pharmacologic and Lifestyle Interventions to Modulate the Epigenome in Heart Failure	11
Preload Reduction Therapies in Heart Failure	11
Genetics of High-Altitude Pulmonary Edema	11
Medical Therapy and Monitoring in Adult Congenital Heart Disease Heart Failure	10
Arrhythmias in Adult Congenital Heart Disease Heart Failure	10
Contributors	10
Genetic Determinants of Response to P2Y12 Inhibitors and Clinical Implications	10
Emerging Roles for Artificial Intelligence in Heart Failure Imaging	9
Heart Failure Clinics	9

Coronary Angiography in the Evaluation of Systolic Heart Failure	9
Copyright	9
What Is New in Risk Assessment in Nuclear Cardiology?	8
Contributors	8
The Role of Echocardiography for the Clinical Diagnosis, Risk Stratification, and Management of Cardiac Amyloidosis	8
Special Considerations for Mechanical Circulatory Support or Device Therapy in Adult Congenital Heart Disease Heart Failure	8
Specific Therapy in Transthyretin Amyloid Cardiomyopathy	7
Hypertrophic Cardiomyopathy	7
Guide to Temporary Mechanical Support in Cardiogenic Shock	7
Arrythmia-Mediated Valvular Heart Disease	7
Myocardial Dysfunction in Patients with Cancer	7
Redefining Left Ventricular Systolic Dysfunction in Hypertrophic Cardiomyopathy	7
Cardiac Contractility Modulation	6
Interventional Management of Atrial Fibrillation in the Chronic Heart Failure Population	6
Evaluation and Management of Cardiac Sarcoidosis with Advanced Imaging	6
Cardiac Amyloidosis	6
Pulmonary Arterial Hypertension in Connective Tissue Diseases Beyond Systemic Sclerosis	6
The Role of Multimodality Imaging in the Evaluation of Heart Failure and Surgical Transplant Planning of Patients with Adult Congenital Heart Disease	6
Obtaining a Coronary Artery Calcium Score with Myocardial Perfusion Imaging	6
Shifting the Epigenetic and Multi-Omic Frontier to Get the Heart in Top Gear	6
Glucose-Lowering and Metabolic Effects of SGLT2 Inhibitors	6
SGLT2 Inhibitors in Heart Failure	6
Noncoding RNAs in Pulmonary Arterial Hypertension	6
Preface	5
Contributors	5
Contents	5
Contents	5
Copyright	4
Epigenetics of Heart Failure	4
Radionuclide Tracers for Myocardial Perfusion Imaging and Blood Flow Quantification	4
Aortic Valvular Stenosis and Heart Failure	4
Exercise Training and Rehabilitation in Cardiac Amyloidosis (ERICA) Study	4
SGLT2 Inhibitors in Type 2 Diabetes Mellitus	4
Contents	4
Adults with Congenital Heart Disease and Transplant	4
The Direct and Indirect Effects of COVID-19 on Acute Coronary Syndromes	4
Evolving Strategies in Cardiac Amyloidosis	4
Copyright	4
Contents	4
Vision Statement and Call to Action for Adult Congenital Heart Disease Heart Failure	3
Clinical Practice Guidelines in Cardio-Oncology	3
Contributors	3
Evaluation and Management of Arrhythmias in Ischemic Cardiomyopathy	3
The Role of Medical Therapy in Hypertrophic Cardiomyopathy	3
Remote Monitoring Devices and Heart Failure	3
Advances in the Therapy of Light Chain Cardiac Amyloidosis	3
Mechanical Complication of Acute Myocardial Infarction Secondary to COVID-19 Disease	3
Contents	3
SGLT2 Inhibitors and Peripheral Vascular Events	3
Coronary Microvascular Dysfunction	3

Risk Factors for Progression in Hypertrophic Cardiomyopathy	3
Exercise Testing in Pulmonary Hypertension and Heart Failure	3
Contents	3
Clinical Value of Positron Emission Tomography Myocardial Perfusion Imaging and Blood Flow Quantification	2
Pathophysiology of Cardiac Amyloidosis	2
Novel Non-pharmacological Approaches to Heart Failure	2
Multiomics Insights into Epigenetic Mechanisms and Their Role as Biomarkers for Acute Coronary Syndrome	2
Copyright	2
Epigenetic Regulation in Dilated Cardiomyopathy	2
Changing Landscape of Heart Failure Imaging	2
Pulmonary Hypertension in Adult Congenital Heart Disease–Related Heart Failure	2
Forthcoming Issues	2
Forthcoming Issues	2
Copyright	2
Contents	2
Contributors	2
Adult Congenital Heart Disease	2
Multimodality Imaging in the Evaluation of Hypertrophic Cardiomyopathy	2
Latest Updates in Heart Failure Imaging	2
Forthcoming Issues	2
Clinical Use of Biomarkers in Cardiac Amyloidosis	2
Sequencing Quadruple Therapy for Heart Failure with Reduced Ejection Fraction: Does It Really Matter?	2
Long-term Complications of Venous Thromboembolism	2
Forthcoming Issues	2
Genetics of Thoracic and Thoracoabdominal Aortic Dissections and Aneurysms	2
Novel Approaches to Sleep Apnea in Heart Failure	2
Heart Failure Staging and Indications for Advanced Therapies in Adults with Congenital Heart Disease	2
Novel PET Applications and Radiotracers for Imaging Cardiovascular Pathophysiology	1
Obesity in Heart Failure with Reduced Ejection Fraction	1
Forthcoming Issues	1
Patient Selection, Referral Framework and Emerging Therapies in Severe Ischemic Heart Failure	1
Challenges in Pulmonary Hypertension	1
Translational Cardio-Oncology Research to Promote Better Outcomes for One and All	1
Mechanical Circulatory Support in COVID-19	1
Imaging in Hypertrophic Cardiomyopathy: Beyond Risk Stratification	1
Monitoring for Valve Decrepitude: Surveillance Echo for All at Age 60…?	1
Percutaneous Coronary Intervention for Heart Failure due to Coronary Artery Disease	1
Contents	1
Copyright	1
SGLT2 Inhibitors in Heart Failure with Reduced Ejection Fraction	1
Contributors	1
Nuclear Cardiology	1
Secondary Mitral Regurgitation and Transcatheter Mitral Valve Therapies	1
Sodium Glucose Cotransporter 2 Inhibitors, Amputation Risk, and Fracture Risk	1
Review of Immunologic Manifestations of COVID-19 Infection and Vaccination	1
Radionuclide Imaging of Infective Endocarditis	1
Venous Thromboembolism in Women and Gender-Diverse Populations	1
Portopulmonary Hypertension	1
Approach to Mitral Regurgitation in Advanced Heart Failure	1
Pediatric and Familial Genetic Arrhythmia Syndromes	1
Cardiac PET Imaging for Coronary Artery Disease and Heart Failure	1
Radionuclide Assessment of Sarcoidosis	1
Contributors	1
A Review of ST-Elevation Myocardial Infarction in Patients with COVID-19	1
Copyright	1
Contents	1
Use of Oral Anticoagulant Drugs in Patients with Pulmonary Hypertension	1
Contents	1
SGLT2 Inhibitors and Heart Failure with Preserved Ejection Fraction	1
Valvular Heart Failure due to Tricuspid Regurgitation	1
Forthcoming Issues	0
Copyright	0
Copyright	0
The Evolving Landscape of Hypertrophic Cardiomyopathy	0
Forthcoming Issues	0
Copyright	0
Evaluation of Coronary Artery Disease and Ischemia by Echocardiography	0
Unique Challenges of Adult Congenital Heart Disease in CardioOncology	0
Challenges in Pulmonary Hypertension	0
Forthcoming Issues	0
Cardioprotection of High-Risk Individuals	0
Nuclear Cardiology in 2023	0
Amyloidosis and Amyloidogenesis	0
Contributors	0
Cardiopulmonary Exercise Testing, Rehabilitation, and Exercise Training in Postpulmonary Embolism	0
Cardiac Implantable Electronic Devices in Ischemic Cardiomyopathy	0
Use and Prognostic Implications of Cardiac Troponin in COVID-19	0
Contents	0
Standard Therapy in Cardiac Amyloidosis	0
Contributors	0

T-cell Immunotherapy and Cardiovascular Disease	0
Frailty and Its Implications in Heart Failure with Reduced Ejection Fraction	0
The Ability of Near-Infrared Spectroscopy to Identify Vulnerable Patients and Plaques: A Systematic Review and Meta-Analysis	0
Coronary Artery Disease and Heart Failure	0
Heart Failure with Reduced Ejection Fraction	0
Renoprotective Effects of SGLT2 Inhibitors	0
Exercise Testing in Elite Athletes	0
Copyright	0
Hypertrophic Cardiomyopathy in the Absence of “Hypertrophy”	0
Sex-Based Differences in Advanced Heart Failure	0
Forthcoming Issues	0
Copyright	0
Genotype-Phenotype Correlations in ATTR Amyloidosis	0
Obesity Management for Patients with Coronary Artery Disease and Heart Failure	0
Exercise Training in Patients with Chronic Thromboembolic Pulmonary Hypertension and Pulmonary Arterial Hypertension	0
Advances in the Diagnosis of Chronic Thromboembolic Pulmonary Hypertension	0
Baroreflex Activation Therapy in Patients with Heart Failure with a Reduced Ejection Fraction	0
Assessment of Right Ventricle Function and Tricuspid Regurgitation in Heart Failure: Current Advances in Diagnosis and Imaging	0
Intracellular Signaling Pathways Mediating Tyrosine Kinase Inhibitor Cardiotoxicity	0
Contributors	0
Contributors	0
Contributors	0
Contributors	0
The Diagnostic and Prognostic Role of Focused Cardiac Ultrasound Performed by Non-cardiologist Specialists in Acute Symptomatic Pulmonary Embolism	0
The Non-invasive Assessment of the Pulmonary Circulation-Right Ventricular Functional Unit	0
Arrhythmic Stratification of Cardiac Amyloidosis	0
Epigenomics and Epigenetics in Heart Failure with Preserved Ejection Fraction	0
Multimodality Imaging in Aortic Stenosis	0
Failing with Cyanosis-Heart Failure in End-Stage Unrepaired or Partially Palliated Congenital Heart Disease	0
Palliative Care in Adult Congenital Heart Disease–Associated Advanced Heart Disease	0
The Economic Burden of Heart Failure with Reduced Ejection Fraction	0
Cardiopulmonary Exercise Testing in Research	0
Navigating the Evolving Landscape of Hypertrophic Cardiomyopathy	0
Contents	0
Viability and Congestive Heart Failure	0
Copyright	0
Impact of Coronavirus Disease 2019 Pandemic on Cardiac Arrest and Emergency Care	0
Cardiac Amyloidosis	0
Modeling Susceptibility to Cardiotoxicity in Cancer Therapy Using Human iPSC-Derived Cardiac Cells and Systems Biology	0
Cardiopulmonary Exercise Testing in Pulmonary Hypertension	0
SGLT2 Inhibitors Are Lifesavers in Heart Failure	0
Coronary Artery Disease and Heart Failure—Continued Significant Morbidity and Mortality Highlights Need for Comprehensive Evaluation to Individualize Patient Management	0
Contributors	0
Approach to Ventricular Arrhythmias in Heart Failure	0
Racial, Ethnic, and Gender Disparities in Valvular Heart Failure Management	0
Surgical Considerations in Adult Congenital Heart Disease Heart Failure	0
Copyright	0
Contents	0
Sodium-Glucose Cotransporter-2 Inhibitors: Impact on Atherosclerosis and Atherosclerotic Cardiovascular Disease Events	0
The War Against Heart Failure Hospitalizations	0
Contents	0
Epigenetic Therapeutics in Human Heart Failure	0
Forthcoming Issues	0
Navigating Complexity: Contemporary Patient Selection and Advanced Therapies in Heart Failure	0
Strategy for Exercise Restriction in Hypertrophic Cardiomyopathy	0
Secondary Mitral Regurgitation and Heart Failure	0
Microscopic Examination of Clots from Percutaneous Mechanical Embolectomies in Pulmonary Embolism	0
Oxygen Therapy in Pulmonary Vascular Disease	0
Sudden Death Risk Assessment in Hypertrophic Cardiomyopathy Across the Lifespan	0
Contributors	0
Interatrial Shunt Devices	0
Contents	0
Extracardiac Prothrombotic Effects of COVID-19	0
Copyright	0
Primary Mitral Regurgitation and Heart Failure	0
SGLT-2 Inhibitors	0
Long-term Complications of Pulmonary Embolism	0
How to Start an Invasive Cardiopulmonary Exercise Testing Program	0
Impact of Hormonal-Anabolic Deficiencies in Idiopathic Pulmonary Arterial Hypertension	0
Valvular Heart Disease and Heart Failure	0
How to Treat Right Heart Failure. Tips for Clinicians in Everyday Practice	0
Surgical Revascularization Decisions in Ischemia and Heart Failure	0
Forthcoming Issues	0
Evaluation of Coronary Artery Disease and Ischemia by Cardiac Magnetic Resonance Imaging	0
Contents	0
Cardiovascular Imaging in Cardio-Oncology	0
Heart Failure Preserved Ejection Fraction in Women	0
Pregnancy and Pulmonary Hypertension	0
Covid-19	0
Copyright	0
Contents	0
Optimizing Patient Selection, Referral Timing, and Advanced Therapies in Cardiogenic Shock	0
Cardiovascular Effects of COVID-19	0
Stress-First Myocardial Perfusion Imaging	0
Tricuspid Regurgitation and Right Heart Failure	0
Immune Dysregulation in Ischemic Heart Disease Among Individuals with Human Immunodeficiency Virus	0
The Emerging Role of Artificial Intelligence in Valvular Heart Disease	0
Targeted Therapies for Microvascular Disease	0
Contents	0
The Uncertain Benefit from Implantable Cardioverter-Defibrillators in Nonischemic Cardiomyopathy	0
PET Imaging for Cardiomyopathy Challenges Simplistic Notions of Ischemia and Viability	0
Left Ventricular Assist Device and the Current State of the Art: HeartMate 3 at 5 Years	0
Training and Career Development in Cardio-Oncology Translational and Implementation Science	0
Heart Failure with Reduced Ejection Fraction and COVID-19, when the Sick Get Sicker	0
Amyloid Cardiomyopathies: Clinical, Diagnostic and Therapeutic Aspects	0